Choice of antibiotics in community acquired UTI due to Escherichia coli in adult age group

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 3, 2011, Pages 483-485

  Rani, Hena ^a   Kaistha, Neelam ^a   Gupta, Varsha ^a   Chander, Jagdish ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Antibiotic; Escherichia coli; Outpatient; UTI

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFEPIME PLUS TAZOBACTAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMMUNICABLE DISEASE; CONTROLLED STUDY; DRUG CHOICE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; INDIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; URINARY TRACT INFECTION; URINE CULTURE;

ESCHERICHIA COLI;

EID: 79959301517     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Khameneh ZR, Afshar AT. Antimicrobial susceptibility pattern of urinary tract pathogens. Saudi J Kidney Dis Transpl 2009;20:251-253.
2. Crichton PB 1999 Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera. In:Collee JG, Fraser AG, Marmion BP, Simmons A (eds) Mackie & McCartney Practical Medical Microbiology,14th edn. Churchill Livingstone, Ch20, p361-384.
3. Clinical and Laboratory Standards Institute: Performance standard for antimicrobial susceptibility testing; Eighteenth Informational Supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, Pa 9th edition. 2008.
4. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Disease Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15:216-227.
5. Gupta V, Yadav A, Joshi RM. Antimicrobial resistance pattern in uropathogens. Indian J Med Microbiol 2002;20: 96-98.
6. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 2003;36:183-187.
7. Keah SH, Wee EC, Chng KS, Keah KC. Antimicrobial susceptibility of community acquired uropathogens in general practice. Malaysian Family Physician 2007;2:64-69.
8. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4.
9. Biswas D, Gupta P, Prasad R, Singh V, Arya M, Kumar A. Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. Indian J Med Sci 2006;60:53-58.
10. Honderlick P, Cahen P, Gravisse J, Vignon D: Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?. Pathol Biol 2006;54:462-466.
11. Gupta V, Datta P. Extended-spectrum beta-lactamases (ESBL) in community isolates from north India: frequency and predisposing factors. Int J Infect Dis 2007;11:88-89.
12. Dyer IE, Sankary TM, Dawson JA. Antibiotic resistance in bacterial urinary tract infections,1991-1997. West J Med 1998;169:265-268.